About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ctsstm1Hap
targeted mutation 1, Harold A Chapman
MGI:2182133
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ctsstm1Hap/Ctsstm1Hap B6.129S2-Ctsstm1Hap MGI:3573791
cx2
Ctsstm1Hap/Ctsstm1Hap
Ldlrtm1Her/Ldlrtm1Her
B6.129S-Ctsstm1Hap Ldlrtm1Her MGI:5008733
cx3
Ctsstm1Hap/Ctsstm1Hap
Dmdmdx/Dmdmdx
involves: 129S2/SvPas * C57BL/10ScSn MGI:5779560
cx4
Ctsstm1Hap/Ctsstm1Hap
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
involves: 129S2/SvPas * C57BL/6 * CBA MGI:5008742


Genotype
MGI:3573791
hm1
Allelic
Composition
Ctsstm1Hap/Ctsstm1Hap
Genetic
Background
B6.129S2-Ctsstm1Hap
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctsstm1Hap mutation (3 available); any Ctss mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• very weak in vitro T cell proliferative responses to either whole AChR protein or peptides, indicating the supporting T cell repertoire never fully developed
• purified splenocyte antigen presenting cells were impaired in their ability to stimulate highly primed wildtype CD4+ T cells in vitro with AChR protein, indicating impaired Ag presentation
• reduced B cell responses to acetylcholine receptor
• despite repeated immunization of homozygous null mice with AChR protein, there was little B cell expansion
• reduced anti-AChR IgG1, IgG2b, IgG2c subclass production in AChR-immunized homozygotes
• reduced anti-AChR IgM production in AChR-immunized homozygotes
• reduced humoral responses in AChR immunized homozygotes
• production of IFN-gamma was suppressed in lymph node cells from AChR immunized homozygotes that were stimulated in vitro with AChR protein or peptides
• production of IL-2 and IL-10 was suppressed in lymph node cells from AChR immunized homozygotes that were stimulated in vitro with AChR protein or peptides
• homozygous null mice were markedly resistant to the development of experimental autoimmune myasthenia gravis (EAMG) (induced by acetylcholine receptor (AChR) immunization), with 17% of nulls developing EAMG compared to 75% of wildtype, and had significantly higher functional muscle acetylcholine receptors

cardiovascular system
• during wound healing, microvessel development is impaired compared to in wild-type mice
• endothelial cells exhibit impaired matrigel and collagen gel invasion compared with wild-type cells

hematopoietic system
• reduced B cell responses to acetylcholine receptor
• despite repeated immunization of homozygous null mice with AChR protein, there was little B cell expansion
• reduced anti-AChR IgG1, IgG2b, IgG2c subclass production in AChR-immunized homozygotes
• reduced anti-AChR IgM production in AChR-immunized homozygotes
• very weak in vitro T cell proliferative responses to either whole AChR protein or peptides, indicating the supporting T cell repertoire never fully developed




Genotype
MGI:5008733
cx2
Allelic
Composition
Ctsstm1Hap/Ctsstm1Hap
Ldlrtm1Her/Ldlrtm1Her
Genetic
Background
B6.129S-Ctsstm1Hap Ldlrtm1Her
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctsstm1Hap mutation (3 available); any Ctss mutation (32 available)
Ldlrtm1Her mutation (19 available); any Ldlr mutation (81 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• after 12 and 26 weeks on an atherogenic diet with decreased macrophage, leukocyte, and CD4+ T cells within lesions

immune system
• leukocytes exhibit impaired leukocyte transmigration compared with wild-type cells

homeostasis/metabolism
• when fed standard chow

muscle

cellular
• leukocytes exhibit impaired leukocyte transmigration compared with wild-type cells

hematopoietic system
• leukocytes exhibit impaired leukocyte transmigration compared with wild-type cells




Genotype
MGI:5779560
cx3
Allelic
Composition
Ctsstm1Hap/Ctsstm1Hap
Dmdmdx/Dmdmdx
Genetic
Background
involves: 129S2/SvPas * C57BL/10ScSn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctsstm1Hap mutation (3 available); any Ctss mutation (32 available)
Dmdmdx mutation (31 available); any Dmd mutation (154 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• treadmill running time is decreased as compared to wild-type, but increased as compared to homozygous Dmdmdx mice

homeostasis/metabolism
• treadmill running time is decreased as compared to wild-type, but increased as compared to homozygous Dmdmdx mice
• increase in serum creatine kinase levels as compared to wild-type, but decreased as compared to homozygous Dmdmdx mic

muscle
• decreased membrane stability as compared to wild-type, but increased as compared to homozygous Dmdmdx mice
• increase in central nucleation at 2 and 10 months of age as compared to wild-type, but decreased as compared to homozygous Dmdmdx mice
• myofiber necrosis is increased as compared to wild-type, but decreased as compared to homozygous Dmdmdx mic
• fibrosis at 2 months and 10 months is increased as compared to wild-type, but decreased as compared to homozygous Dmdmdx mice
• increased as compared to wild-type, but decreased as compared to homozygous Dmdmdx mice




Genotype
MGI:5008742
cx4
Allelic
Composition
Ctsstm1Hap/Ctsstm1Hap
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ctsstm1Hap mutation (3 available); any Ctss mutation (32 available)
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• following treatment with doxycycline but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• doxycycline-treated mice exhibit increased lung volume compared to in wild-type mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• following treatment with doxycycline but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice

immune system
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice

cellular
• in lung cells following treatment with doxycycline but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice

hematopoietic system
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice
• in the bronchoalveolar lavage of doxycycline-treated mice but not as much as in Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory